iOS app Android app

Ivac

Talking Global Health Is Talking Jobs

Dr. Orin Levine | Posted 09.19.2012 | Impact
Dr. Orin Levine

As the campaigns start looking to win over every vote in the pivotal swing states, it may be worth examining more closely the local links between global health and jobs, and the opportunity to tap into an issue that could energize university students.

Routine Vaccination Solutions for Nigeria Will Save Lives and Money

Tom Murphy | Posted 07.10.2012 | Impact
Tom Murphy

Nigeria is home to one out of every eight child deaths worldwide, and the Decade of Vaccines Economics projects 90 percent vaccine coverage can save 600,000 lives and $17 billion in Nigeria over the next 10 years.

Good Things Come in Different-Sized Packages

Dr. Orin Levine | Posted 07.08.2012 | Impact
Dr. Orin Levine

Decisions around vaccine container size and type -- whether single-dose vial, multi-dose container or pre-filled syringe -- have important implications for a variety of stakeholders.

Global Motherhood: Perils And Promise In Ghana

Dr. Orin Levine | Posted 06.26.2012 | Home
Dr. Orin Levine

In the United States, we can practically start planning our kids' birthdays from the day they come home from the hospital; deaths in childhood are quite rare. In Ghana, though, you can't take a child's fifth birthday for granted.

First Steps Toward the Last Mile in Nigeria

Dr. Orin Levine | Posted 06.13.2012 | Impact
Dr. Orin Levine

Likewise, as one of only three remaining countries in the world with endemic polio transmission, they have recently ramped up efforts to eradicate polio from the country, and thereby, help rid it from the entire world.

10 Years of Vaccine Progress in 10 Days

Dr. Orin Levine | Posted 08.09.2011 | Impact
Dr. Orin Levine

Finding the right balance between affordable prices, innovation, and supply security will require hard work, patience, and a long-term view.

Our Germs in the Gorillas' Midst

Dr. Orin Levine | Posted 06.05.2011 | World
Dr. Orin Levine

With the expanded use of life-saving interventions like the pneumococcal vaccine, we need to learn as much as possible about the remaining causes of severe pneumonia in children as we can.